A Study to Evaluate the Effects of ACT-541468 on Respiration in Patients With Moderate Chronic Obstructive Pulmonary Disease
Clinical trial NCT03646864 · COMPLETED
Trial details
- NCT number
- NCT03646864
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2019-09-19
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.